Table of Contents
The global sleep apnea devices market is expected to witness substantial growth owing to high prevalence of Obstructive Sleep Apnea (OSA) patients. Downsides of urban lifestyle such as long working hours, obesity, diabetes, and anxiety have resulted in increased sleep disorders, consequently driving sleep apnea devices demand. Leading market players have invested heavily in the development of compact therapeutic devices, which is expected to favorably impact sleep apnea devices market growth. Lack of patient compliance and discomfort caused by the devices may pose a challenge to industry participants.
Further Key findings from the study suggest:
Diagnostic sleep apnea devices accounted for over 50% of the overall market in 2013; however, they are expected to lose market share to therapeutic devices by 2020, which are projected to overtake the former.
PSG devices contributed over 25% to the overall diagnostic sleep apnea devices market revenue in 2013. PAP devices accounted for over 20% of the overall therapeutic sleep apnea devices market revenue in 2013. Oral appliances are expected to gain therapeutic devices market share over the forecast period.
North America dominated the market in 2013, accounting for approximately 35% of the overall revenue. This can be attributed to increased sleep apnea awareness, increased obesity among the population, sophisticated healthcare infrastructure and high insurance coverage in the region. The Asia Pacific sleep apnea devices market is relatively untapped and has high growth potential over the forecast period, with the level of awareness projected to increase among patients and the medical fraternity.
The sleep apnea devices market is highly consolidated, with ResMed and Philips Respironics accounting for a considerable percentage of the overall revenue. Other manufacturers include Weinmann Medical Devices, Natus Medical, Fisher & Paykel Healthcare, DeVilbiss Healthcare, and CareFusion.
For the purpose of this study, Grand View Research has segmented the global sleep apnea devices market on the basis of product and region:
Sleep Apnea Devices Product Outlook (Revenue, USD Million, 2012 – 2020)
- Diagnostic Devices
- Actigraphy Systems
- Polysomnography (PSG) Devices
- Respiratory Polygraph
- Single Channel Screening Devices (Pulse Oximeters)
- Therapeutic Devices
- Adaptive Servo Ventilation (ASV) Systems
- Airway Clearance Systems
- Positive Airway Pressure (PAP) Devices
- Oral Appliances
- Oxygen Devices
Sleep Apnea Devices Regional Outlook (Revenue, USD Million, 2012 – 2020)
- North America
- Asia Pacific
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Global Medical Oxygen Concentrators Market: Overview Medical oxygen concentrators are used by patients suffering from COPD and other respiratory diseases. Patients having low level of oxygen in their blood ...
The respiratory care devices market is expected to grow at a lucrative CAGR of 9.7% from 2016 to 2021, to reach USD 24.07 billion by 2021 from USD 15.14 billion in 2016. Market growth can be attributed ...
The sleep apnea devices market is projected to reach USD 6.70 billion by 2021 from USD 4.59 billion in 2016, growing at a CAGR of 7.8% during the forecast period. The growth of the overall sleep apnea ...
Health Care Pro...